| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0044 | 1 |